Osvaldo D. Rivera, PhD

Posted by Osvaldo D. Rivera, PhD | July 6, 2024
Leveraging Dormant Data in Biotechnology

The past decade has witnessed a dramatic reduction in the cost of high-throughput technologies, making data generation more accessible than ever. For instance, the cost of sequencing a human genome...

Continue Reading
Posted by Osvaldo D. Rivera, PhD | December 27, 2023
How to establish a biotech business entity in Puerto Rico to commercialize academic research

Puerto Rico has been recently designated as one of the 31 Tech Hubs in the United States, formally pronounced for the advancement of biotechnology, biopharmaceuticals and biomanufacturing. In Puerto Rico,...

Continue Reading
Posted by Osvaldo D. Rivera, PhD | January 3, 2023
Encoding therapies: RNA-based drugs reshaping healthcare

RNA-based therapeutic drugs have been recently advancing clinical trials and into the healthcare industry. RNA, or ribonucleic acid, is a fundamental biomolecule essential for the expression of genes encoded in...

Continue Reading
Posted by Osvaldo D. Rivera, PhD | February 7, 2021
2020 A Pivotal Year for Life Science in Philadelphia

An ‘unprecedented’ year for biotechnology in Philadelphia. The State of Pennsylvania saw a total of $1.47 billion in venture capital investment and growth in 2020, a decline from 2019's whooping...

Continue Reading